2014 AGA Spring Postgraduate Course
2014 AGA Spring Postgraduate Course: Best Practices at the Bedside: Critical Thinking for Common Conditions
Learn from the foremost experts on GI and hepatology and exercise your mind on the latest information in practical use for the clinician at the bedside of the patient. Optional clinical challenge sessions and lunch breakout sessions allow you to delve deeper into 14 clinical topics and give you the opportunity to work in small groups. You will leave this course with new and improved approaches to clinical problems seen in everyday practice.
The 2014 Spring Postgraduate Course schedule is Saturday, May 3, 8:15 a.m.–5:30 p.m. and Sunday, May 4, 8:30 a.m.–12:35 p.m.
Course Director: David Rubin, MD, AGAF
Co-Directors: Bruce Bacon, MD, AGAF and Grace Elta, MD, FASGE
Inflammatory Bowel Disease
- Why is My Patient Not Responding to Conventional Therapies?
- Optimizing Biological Therapy: How to Maximize Response and Assess Loss of Response
- Managing IBD as a Chronic Disease: What Do We Monitor? How Do We Prevent Complications?
- Assessment of Extra-Intestinal Manifestations of IBD: When Is It the Disease? When Is It the Therapy?
Functional Bowel Disorders
- Bloating and Gas: The Role of Diet, Probiotics and Additional Therapies
- Management of Constipation: Pelvic Floor, Motility and New Treatment Strategies
- Evaluation of IBS-D Anthony Lembo
- Functional Upper GI/Dyspepsia
- Benign Biliary Strictures: Etiology and Treatment Options?
- Indeterminate/Malignant Biliary Strictures: Diagnostic Methods and Treatment Choices
- Chronic Pancreatitis Pain: Medical, Endoscopic and Surgical Therapy
- Idiopathic Acute Recurrent Pancreatitis: Diagnosis and Treatment
- Barrett’s Esophagus: Is Screening/Surveillance Worthwhile?
- Barrett’s Esophagus: Does Image Enhancement, Endomicroscopy or Molecular Tagging Have Legs?
- Update on EOE
- Celiac Sprue: When to Test and How to Test
- NSAIDs, Aspirin, Clopidogrel and PPIs: Risk of Damage and When to Use Prophylaxis
- Management of Coagulation Disorders in Cirrhosis: How Anxious Should We Be?
- Choosing the Optimal HCV Regimen
- Alcoholic Hepatitis and Management of Acute on Chronic Liver Disease
- Hepatocellular Carcinoma: Surveillance, Diagnosis and Treatment
- NAFLD and NASH: Moving the Needle
- Colonoscopy Prep Decisions in 2014
- Prevention of CRC: How to Improve our Adenoma Detection Rate
- The Defiant Polyp: Rules of Engagement
- Anti-Coagulants/Anti-Platelet Agents: Management Before, During and After Endoscopy
- When to Refer your Polyp Patient for Genetic Assessment?
- Fecal Microbial Transplant: What are the Indications, How to Do It and What is the Future?
Early-bird registration is now open and can be accessed at www.ddw.org. Register for this course by March 26 and save $75.
- Assimilate the current best practices for managing colonoscopy preparations, and anti-coagulants/anti-platelet agents in the peri-procedure period.
- Understand the common causes and incorporate the current treatment options for benign and malignant biliary strictures.
- Reevaluate your approach to the management of chronic pancreatitis pain and idiopathic acute recurrent pancreatitis.
- Understand the latest approach to optimizing therapy in patients with IBD.
- Adopt an updated approach, including appropriate motility assessment for the patient with functional bowel disorders or suspected motility disorders.
- Understand the newest approach for treating hepatitis C.
- Critically assess our approach to Barrett’s esophagus screening and surveillance.
- Develop an updated approach to the patient with NAFLD, NASH or alcoholic liver disease.
- Update the approach to screening for HCC in the patient with cirrhosis.
The AGA Institute is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AGA Institute designates this live activity for a maximum of 12 AMA PRA Category 1 Credits™.
In accordance with the ACCME’s Standards for Commercial Support of Continuing Medical Education, all faculty and planning partners must disclose any financial relationship(s) or other relationship(s) held within the past 12 months. The AGA Institute implements a mechanism to identify and resolve all conflicts of interest prior to delivering the educational activity to learners.